InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the full record of transactions filed by Barnett Eva Renee, Chief Financial Officer. Insider active across 1 companies, notably Immunovant, Inc.. Aggregated, 6 filings have been published. Total volume traded: €385k. The latest transaction was disclosed on 7 January 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
€192,26829,959 shares@ €6.41770.0034% mcap100.0% of flow
Common Stock
SEC:0001764013-22-000011·
€192,26829,959 shares@ €6.41770.0034% mcap50.0% of flow
Common Stock
SEC:0001764013-22-000011:0·
0143,000 shares0
Common Stock
SEC:0001764013-21-000108·
0143,000 shares0
Common Stock
SEC:0001764013-21-000108:0·
059,500 shares0
Common Stock
SEC:0001764013-21-000106·
059,500 shares0
Common Stock
SEC:0001764013-21-000106:0·
6 of 6 declarations
About Barnett Eva Renee
Eva Renee Barnett is the Chief Financial Officer of Immunovant, Inc. She is responsible for the financial management of the company, including budgeting and financial performance analysis.
